📰 Human Use News
Page 21 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
January 26, 2024
LONDON (Reuters) -The EU's drug regulator said on Friday it would continue to review whether Novo Nordisk's popular weight-loss drug Wegovy could also be used in some cases to reduce the risk of strokes and heart attacks. The expert panel assessing Novo's request to include certain heart benefits in the product's label did not adopt an opinion, a spokesperson for the regulator said. "The application is still under review and we cannot speculate on when it will conclude...
January 26, 2024
Thursday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a negative opinion following the…
January 26, 2024
(Reuters) -PTC Therapeutics said on Thursday the European health regulators advisory panel reaffirmed a negative opinion for its drug used to treat an ...
January 26, 2024
SAN DIEGO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether PTC Therapeutics, Inc. (
January 26, 2024
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation ...
January 26, 2024
SOUTH PLAINFIELD - PTC Therapeutics, Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a negative opinion following the...
January 26, 2024
By Colin Kellaher Bristol Myers Squibb on Friday said the European Medicines Agencys Committee for Medicinal Products for Human Use recommended approval of earlier use of the Abecma gene...
January 26, 2024
WALTHAM, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency
January 26, 2024
OPENING CALL Stock futures fell as a disappointing sales outlook from Intel had traders pushing equities lower. Intel shares were down more than 10% in premarket trading, and the selloff... -January 26, 2024 at 06:22 am EST - MarketScreener
January 26, 2024
Apellis Pharmaceuticals, Inc. (APLS) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a negative opinion for Pegcetacoplan for geographic atrophy or GA.